Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

H. Lundbeck A/S
Sponsor

H. Lundbeck A/S

Denmark Ottiliavej 9, 2500, Denmark

About the sponsor

H. Lundbeck A/S is strongly focused on migraine care, with research spanning chronic migraine, episodic migraine, paediatric migraine, and medication overuse headache. Its studies also address preventive treatment needs in both adults and younger populations.

  • Chronic migraine
  • Episodic migraine
  • Paediatric migraine
  • Medication overuse headache

The sponsor’s clinical portfolio includes interest in reducing migraine frequency and supporting long-term management across age groups.

About Specializations

H. Lundbeck A/S runs clinical trials in conditions such as Migraine, Parkinson's disease, Multiple system atrophy, Endocrine ophthalmopathy, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

9 clinical trials

Migraine

Recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Eptinezumab
  • Sponsor:H. Lundbeck A/S

Parkinson's disease

Not yet recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:H. Lundbeck A/S

Multiple system atrophy

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:AMLENETUG
  • Sponsor:H. Lundbeck A/S

Endocrine ophthalmopathy

Not recruiting
InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Human (Scfv)2-Fab Fusion Protein Against Cd40L
  • Sponsor:H. Lundbeck A/S

Migraine+1

Not recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Eptinezumab
  • Sponsor:H. Lundbeck A/S

Migraine

Not recruiting
Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Eptinezumab
  • Sponsor:H. Lundbeck A/S

Pituitary-dependent Cushing's syndrome

Not recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ag13909
  • Sponsor:H. Lundbeck A/S

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.